×
ESMO Virtual Congress 2020: Meeting
https://www.esmo.org/meetings/esmo-virtual-congress-2020

Sep 17th, 2020 - Bringing innovation to cancer patients. The ESMO Virtual Congress 2020 will present promising new developments aimed at improving cancer patient care. In response to the needs of the moment, the scientific programme will include a dedicated COVID-19 and cancer research track. Take part in Europe's most prestigious platform for oncology stakeholders.

ESMO Guideline for Cancer Patient Management During the COVID-19 Pandemic
https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic?hit=ehp

Sep 17th, 2020 - These recommendations should be used as guidance for prioritising the various aspects of cancer care in order to mitigate the negative effects of the COVID-19 pandemic on the management of cancer patients. The situation is evolving, and pragmatic actions may be required to deal with the challenges of treating patients, while ensuring their rights, safety and wellbeing.

ESMO: COVID-19 and Cancer
https://www.esmo.org/covid-19-and-cancer?hit=ehp

Sep 18th, 2020 - Updates, guides, webinar series, recommendations, more.

ESMO Webinar Series: Managing Patients in the COVID-19 Era
https://www.esmo.org/meetings/esmo-webinar-series/managing-patients-in-the-covid-19-era

Sep 18th, 2020 - This Webinar series has been organised with the aim to share the ESMO adapted recommendations for cancer patient management during the COVID-19 pandemic. These recommendations should be used as guidance for prioritising the various aspects of cancer care in order to mitigate the negative effects of the COVID-19 pandemic on the management of cancer patients.

ESMO Guidelines: COVID-19 Adapted Recommendations Slide Sets
https://www.esmo.org/guidelines/covid-19-adapted-recommendations-slide-sets

Sep 18th, 2020 - The core content of each COVID-19 adapted recommendation is presented in a user-friendly format ready for you to use in your own presentations, both to illustrate your own cases and research, as well as for educational purposes. Please note that while you may use slides individually from the sets for personal use, it is strictly forbidden to alter or hide any of the content, the ESMO logo, the ...

ESMO Virtual Congress 2020: Abstracts
https://www.esmo.org/meetings/esmo-virtual-congress-2020/abstracts

Sep 18th, 2020 - Abstract submission categories Basic science Biliary tract cancer, incl. cholangiocarcinoma Biomarkers (agnostic) Breast cancer, early stage Breast cancer, locally advanced Breast cancer, metastatic CNS tumours Colorectal cancer Developmental therapeutics Endocrine tumours Genitourinary tumours, prostate Genitourinary tumours, non-prostate Gynaecological cancers Haematological mal...

ESMO COVID-19 Full Coverage
https://www.esmo.org/covid-19-and-cancer/covid-19-full-coverage

Sep 18th, 2020 - The COVID-19 pandemic has brought new challenges to clinical practice and research in oncology. ESMO is reporting on the current situation by news and KOLs experiences, and has gathered useful resources to keep medical oncologists updated.

ESMO
https://www.esmo.org/

Sep 18th, 2020 - EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY The leading professional organisation for medical oncology

ESMO: COVID-19 and Cancer Care in the ESMO Journals
https://www.esmo.org/covid-19-and-cancer/covid-19-and-cancer-care-in-the-esmo-journals

Sep 17th, 2020 - In this page you can find the articles related to COVID-19 disease in the context of cancer care management as published in the ESMO flagship journal, the Annals of Oncology and the ESMO Open.

ESMO Virtual Congress 2020: Exhibition
https://www.esmo.org/meetings/esmo-virtual-congress-2020/exhibition

Sep 18th, 2020 - With the new virtual platform, the aim is twofold: on one side to offer an experience which will be able to meet the needs of the many eager to find a fruitful learning opportunity; on the other, we are committed to still offer an engaging networking space, all delivered via state-of-the-art technology. Further information in this regard will be published progressively on this webpage soon.

ESMO Virtual Congress 2020: ESMO Colloquia
https://www.esmo.org/meetings/esmo-virtual-congress-2020/esmo-colloquia

Sep 18th, 2020 - The ESMO Colloquia are innovative sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community. The Colloquia are organised by ESMO and supported by the industry in a unique collaboration making them the perfect complement to the scientific and education programme of the Congress.

ESMO Virtual Congress 2020: Program
https://www.esmo.org/meetings/esmo-virtual-congress-2020/programme

Sep 18th, 2020 - The ESMO Virtual Congress 2020 Programme is now online! The ESMO Virtual Congress 2020 will be the global stage for the exchange and debate of translational cancer science of excellence, first announcements of practice-changing data, and multidisciplinary must-have conversations set to spur transformative therapies against cancer.

Managing cancer patients during the COVID-19 pandemic: An ESMO Interdisciplinary Expert Consensus
https://www.annalsofoncology.org/article/S0923-7534(20)39948-8/fulltext
Annals of Oncology; Curigliano G

Jul 30th, 2020 - We established an international consortium to discuss clinical evidence and to provide expert advice on statements related to cancer management during COVID-19 pandemics. The steering committee prepared ten working packages addressing significant clinical questions from diagnosis to surgery.

Importance of pre-operative ultrasound examination and pathological tumour evaluation i...
https://doi.org/10.1016/j.ejogrb.2020.12.029
European Journal of Obstetrics, Gynecology, and Reproduct... Sobočan M, Ogrizek AM et. al.

Dec 31st, 2020 - Endometrial cancer (EC) is the most common gynaecological malignancy in developed countries. Early and accurate diagnostic assessment is crucial for appropriate treatment planning. Information obtained by pre-operative imaging with transvaginal ultrasound (TVUS) and histological endometrial biopsy assessment is often the cornerstone for further management planning. This study aimed to analyse t...

Impact of restaging lymphadenectomy after sentinel node biopsy on endometrial cancer.
https://doi.org/10.1016/j.ejogrb.2020.12.028
European Journal of Obstetrics, Gynecology, and Reproduct... Gorostidi M, Ruiz R et. al.

Dec 31st, 2020 - Approximately 10 % of patients with an intra-operative diagnosis of low-risk endometrial cancer (EC) will be upstaged after a definitive histological evaluation of hysterectomy and bilateral adnexectomy samples. This study aimed to explore the results associated with the performance of pelvic and para-aortic lymphadenectomy for restaging after upstaging/upgrading these patients, and to compare ...

Adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors i...
https://doi.org/10.1111/cts.12957
Clinical and Translational Science; Yin X, Zhao Z et. al.

Dec 31st, 2020 - The efficacy of agents targeting epidermal growth factor receptor (EGFR) in patients with various cancers was well elucidated. However, the safety profile of EGFR tyrosine kinase inhibitors (EGFR-TKIs) has not been systematically investigated. This meta-analysis aimed to evaluate the safety profile of EGFR-TKIs in patients with cancer. A systematic search of PubMed, EMBASE, Cochrane Library dat...

Prognostic validation and clinical implications of the EANO ESMO classification of lept...
https://doi.org/10.1093/neuonc/noaa298
Neuro-oncology Le Rhun E, Devos P et. al.

Dec 28th, 2020 - The EANO ESMO guidelines have proposed a classification of leptomeningeal metastases (LM) from solid cancers based on clinical, magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) cytology presentation. MRI patterns are classified as linear, nodular, both, or neither. Type I LM is defined by positive CSF cytology (confirmed LM) whereas type II LM is defined by typical clinical and MR...

Diagnosis and Management of Gestational Trophoblastic Disease: A Comparative Review of ...
https://doi.org/10.1097/OGX.0000000000000848
Obstetrical & Gynecological Survey; Tsakiridis I, Giouleka S et. al.

Dec 28th, 2020 - Gestational trophoblastic disease (GTD) is associated with increased mortality and morbidity in women of reproductive age, if managed in a suboptimal way, left untreated, or diagnosed after the development of extensive metastases. The aims of this study were to review and compare the recommendations from published guidelines on these tumors of placental origin. A descriptive review of guideline...